- Main
Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffolds
- Yang, Huilin;
- Ulge, Umut Y;
- Quijano-Rubio, Alfredo;
- Bernstein, Zachary J;
- Maestas, David R;
- Chun, Jung-Ho;
- Wang, Wentao;
- Lin, Jian-Xin;
- Jude, Kevin M;
- Singh, Srujan;
- Orcutt-Jahns, Brian T;
- Li, Peng;
- Mou, Jody;
- Chung, Liam;
- Kuo, Yun-Huai;
- Ali, Yasmin H;
- Meyer, Aaron S;
- Grayson, Warren L;
- Heller, Nicola M;
- Garcia, K Christopher;
- Leonard, Warren J;
- Silva, Daniel-Adriano;
- Elisseeff, Jennifer H;
- Baker, David;
- Spangler, Jamie B
Published Web Location
https://doi.org/10.1038/s41589-023-01313-6Abstract
The interleukin-4 (IL-4) cytokine plays a critical role in modulating immune homeostasis. Although there is great interest in harnessing this cytokine as a therapeutic in natural or engineered formats, the clinical potential of native IL-4 is limited by its instability and pleiotropic actions. Here, we design IL-4 cytokine mimetics (denoted Neo-4) based on a de novo engineered IL-2 mimetic scaffold and demonstrate that these cytokines can recapitulate physiological functions of IL-4 in cellular and animal models. In contrast with natural IL-4, Neo-4 is hyperstable and signals exclusively through the type I IL-4 receptor complex, providing previously inaccessible insights into differential IL-4 signaling through type I versus type II receptors. Because of their hyperstability, our computationally designed mimetics can directly incorporate into sophisticated biomaterials that require heat processing, such as three-dimensional-printed scaffolds. Neo-4 should be broadly useful for interrogating IL-4 biology, and the design workflow will inform targeted cytokine therapeutic development.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.